Natera to Present at the Canaccord Genuity Virtual MedTech & Diagnostics Forum

Rhea-AI Summary

Natera, Inc. (NASDAQ: NTRA) announced a live webcast presentation at the Canaccord Genuity Virtual MedTech & Diagnostics Forum on November 19, 2020, at 1:30 p.m. PT (4:30 p.m. ET). Mike Brophy, Chief Financial Officer, will discuss the company's latest developments. The webcast will be accessible live and archived on investor.natera.com.

Natera, a leader in cell-free DNA testing, aims to transform disease management, focusing on women’s health, oncology, and organ health.

SAN CARLOS, Calif., Nov. 12, 2020 /PRNewswire/ -- Natera, Inc. (NASDAQ: NTRA), a pioneer and global leader in cell-free DNA testing, today announced it will webcast a live presentation at the Canaccord Genuity Virtual MedTech & Diagnostics Forum on Thursday, November 19, 2020, at 1:30 p.m. PT (4:30 p.m. ET).

Mike Brophy, Chief Financial Officer, will discuss Natera's latest developments and business activities.

Access to the live webcast and subsequent archived presentation will be available at investor.natera.com.

About Natera
Natera is a pioneer and global leader in cell-free DNA testing. The mission of the company is to change the management of disease worldwide with a focus on women's health, oncology, and organ health. Natera operates an ISO 13485-certified and CAP-accredited laboratory certified under the Clinical Laboratory Improvement Amendments (CLIA) in San Carlos, California. It offers proprietary genetic testing services to inform obstetricians, transplant physicians, oncologists, and cancer researchers, including biopharmaceutical companies, and genetic laboratories through its cloud-based software platform. For more information, visit natera.com. Follow Natera on LinkedIn. 

Contacts
Investor Relations: Mike Brophy, CFO, Natera, Inc., 510-826-2350
Media: Paul Greenland, VP of Corporate Marketing, Natera, Inc., pr@natera.com

View original content to download multimedia:http://www.prnewswire.com/news-releases/natera-to-present-at-the-canaccord-genuity-virtual-medtech--diagnostics-forum-301171568.html

SOURCE Natera, Inc.

FAQ

When will Natera present at the Canaccord Genuity Virtual MedTech & Diagnostics Forum?

Natera will present on November 19, 2020, at 1:30 p.m. PT.

Who will be speaking at the Canaccord Genuity forum for Natera?

Mike Brophy, Chief Financial Officer, will be presenting.

Where can I access the Natera presentation after the event?

The presentation will be available live and archived at investor.natera.com.

What is the focus of Natera's business discussed in the presentation?

The focus is on cell-free DNA testing, particularly in women's health, oncology, and organ health.